Frieda Robscheit-Robbins

Frieda Saur Robscheit-Robbins (1893-1973) portrait

Friedericke Mathilde Saur (1888-1973) was a German born, American pathologist

Frieda worked alongside George Hoyt Whipple to fundamentally shape our understanding of anaemia and liver therapy. In collaboration with Whipple she helped establish the dietary treatment of anaemia and co-authored nine of the 23 key studies on haemoglobin regeneration and liver therapy between 1920 and 1933.

Robscheit-Robbins participated in critical investigations into red blood cell regeneration, the effects of diet on haematopoiesis, and the use of liver and raw food therapy in anaemia. Her skill in conducting animal studies, particularly in dogs, enabled a level of precision and reproducibility that underpinned the liver therapy which ultimately led to the 1934 Nobel Prize awarded to Whipple, Minot, and Murphy.

Despite her central role in this discovery, Robscheit-Robbins was not included among the laureates. In interviews following the Nobel announcement, she notably expressed no desire for accolades, stating, “It is not honors I want. I am not a student of medicine to make a name. I have tried to do my part. That is all.” Her humility belied the importance of her work, as her meticulous technical execution and scientific judgment provided the essential data Whipple relied upon. The Democrat and Chronicle described her as “the woman who helped win the Nobel Prize”, a quiet force behind a Nobel-winning body of work.

Beyond liver therapy, her work extended to foundational studies in haemoglobin dynamics, iron metabolism, and nutritional biochemistry. She remained a full-time investigator and associate in pathology at the University of Rochester until her retirement in 1955. A generation of physicians and scientists quietly benefitted from her rigour and innovations. Today, her legacy stands as a powerful example of scientific excellence obscured by gendered norms of credit and authorship in early 20th-century medicine. Her story is not one of omission but of enduring impact in the fight against anaemia and in the evolution of clinical haematology.

Biographical Timeline
  • Born on June 8, 1888 in Euskirchen, Germany. Earlier discrepancies (e.g., 1893) are contradicted by contemporary records and her own statements.
  • 1900 – Emigrated to the United States with her parents. Settled in Chicago and then San Francisco.
  • 1915 – Married Hans Theodor Robscheit (1884-1959) taking the name Frieda Mathilde Robscheit.
  • 1917 – Began work as assistant to George Hoyt Whipple (1878-1976) at the Hooper Foundation for medical research, University of California. Birth of daughter Gene Charlotte.
  • 1920 – Published first scientific paper on hemoglobin determination by various methods under the name Frieda Saur Robscheit
  • 1921 – Nominated by Whipple for membership in the Society for Experimental Biology and Medicine as an independent investigator.
  • 1922 – Rejoined Whipple at the newly formed University of Rochester School of Medicine as associate in pathology. Surname of Robscheit, Americanized to Robbins. However, on Whipple’s advice and with prior publications, her professional title became F.S. Robscheit-Robbins
  • 1922-1933 Played a critical role in the liver therapy experiments that led to Whipple, Minot, and Murphy receiving the Nobel Prize in Physiology or Medicine in 1934.
  • 1934 – PhD, University of Rochester on The reserve storage of red cells and hemoglobin and their parent substances during growth in dogs as influenced by diet factors
  • 1950 – First woman president of the American Society for Experimental Pathology
  • 1951 – Married Oscar V. Sprague (1892-1968)
  • 1955 – Retired from the University of Rochester after nearly four decades of research.
  • Died on December 18, 1973 in Tucson, Arizona at the age of 85, not 80 as some obituaries erroneously stated.

Controversies
The Nobel Prize (1934)

Frieda Robscheit-Robbins’ entry into medical research was marked by resilience and sharp defiance of gendered expectations. Raised in Chicago and guided by a physician-guardian, she gravitated toward medical science through hands-on work in commercial pathology labs and later under Gideon Wells at the University of Chicago.

When she applied to work with George Hoyt Whipple at the Hooper Foundation, he initially dismissed the idea of a woman in the dog laboratory, citing the physical demands and messiness of the job.

When, in the course of his first interview with Mrs. Robscheit, he said that he didn’t think much of having a woman in the dog laboratory, she snapped back, “Well, then, Dr. Whipple, here is one woman you don’t have to have in your laboratory!” and started for the door. Whipple, impressed by this show of spirit, called her back and gave her an appointment as Fellow in Research Medicine.

Corner 1963

This bold beginning laid the foundation for a remarkable scientific partnership. When Whipple moved to establish the new medical school at the University of Rochester in 1921, he ensured Robscheit-Robbins joined the staff with the rank of associate in pathology.

During the year 1921-22, Dr. Frieda Robbins in San Francisco had been carrying on the anemia program which we had planned. A colony of standard anemic dogs had been collected and studied with great care.  The Hooper Foundation, with friendly cooperation, permitted Dr. Robbins to continue her laboratory work and occupy a good deal of space in their animal rooms during that year. A most devoted, loyal and able associate over the years, Dr. Robbins carried on through this difficult period most effectively. In December of 1922, Dr. Robbins brought the entire standard anemia dog colony, numbering about forty, including puppies, from California to Rochester where they were properly housed and the research program continued without interruption.

Whipple 1957

There, over the next three decades, she became indispensable to Whipple’s work on anaemia, especially in their long-running studies of blood regeneration using canine models. She designed experiments, performed the laborious animal care and surgical procedures, and co-authored more than 20 major papers including those forming the empirical backbone of Whipple’s Nobel-winning research on liver therapy for anaemia. Despite her central role, Robscheit-Robbins was overlooked by the Nobel Committee in 1934, a decision that continues to raise questions about the recognition of women in collaborative scientific achievement.

In his Nobel Lecture, Whipple lecture acknowledges her involvement noting: “After the transfer of the anemia colony of dogs from San Francisco to Rochester, New York (1923), Dr. Frieda Robscheit-Robbins and the writer began to use a different type of anemia.” He further credits her alongside Dr. Daft in analyzing protein metabolism in anaemia: “the mechanism of this reaction has been investigated by Drs. Daft, Robscheit-Robbins, and Whipple.”

Whipple acknowledged her essential contributions by sharing his one-third share of the Nobel Prize monetary award with her and their long-serving technical assistants, Marie M. Callahan and Doris E. Huxley. The remainder was given to his mother, in gratitude for her support of his medical education, a gesture that further highlights the collaborative nature of his research and the behind-the-scenes contributors who helped shape it.

Her absence from the Nobel citation reflects broader gender inequities in early 20th-century science. Robscheit-Robbins herself seemed unconcerned by the oversight, stating later, “I have no desire for honors.” Still, the historical record is clear: her meticulous laboratory work and experimental leadership were essential to one of the most significant breakthroughs in haematology.


Name variations
  • Friedericke Mathilde Saur
  • Frieda Mathilde Robscheit
  • Frieda Saur Robscheit
  • Frieda S. Robscheit-Robbins
  • Frieda S. Robbins
  • Frieda Sprague (1951-1973)

Major Publications

References

Biography

Eponym

the person behind the name

Dr Laura Gilliland LITFL Author

MB ChB, Edinburgh Medical school. F1/F2 in Bath, now in Australia, Perth preparing for a career in Emergency medicine. I have an interest in wilderness medicine and women’s health, but haven’t fully found my niche interest yet.

BA MA (Oxon) MBChB (Edin) FACEM FFSEM. Emergency physician, Sir Charles Gairdner Hospital. Passion for rugby; medical history; medical education; and asynchronous learning #FOAMed evangelist. Co-founder and CTO of Life in the Fast lane | On Call: Principles and Protocol 4e| Eponyms | Books |

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.